Template:ACLS Narrow Irregular Tachycardia: Difference between revisions

Line 4: Line 4:
**If not symptomatic and rate < 110/120 bpm, may not require treatment (e.g., patient with MAT secondary to COPD)
**If not symptomatic and rate < 110/120 bpm, may not require treatment (e.g., patient with MAT secondary to COPD)
*Sinus Tachycardia with frequent PACs
*Sinus Tachycardia with frequent PACs
**Treat underlying cause
*[[A fib]] / A Flutter with variable conduction (see also [[Atrial Fibrillation with RVR]])
*[[A fib]] / A Flutter with variable conduction (see also [[Atrial Fibrillation with RVR]])
**Check if patient has taken usual rate-control meds
***If missed dose, may provide dose of home medication and observe for resolution
**Determine whether patient is better candidate for rate control or rhythm control <ref>Frankel, G. et al. (2013) Rate versus rhythm control in atrial fibrillation. Canadian Family Physician 59(2), 161 - 168</ref>
***Rate control preferred with:
****Persistent A fib
****Less symptomatic patients
****Age 65 or older
****Hypertension
****No heart failure
****Previous failure to cardiovert
****Patient preference
***Rhythm control preferred with:
****Paroxismal or new A fib
****More symptomatic patients
****Age < 65 years
****Heart failure clearly exacerbated by A fib
****No history of rhythm control failure
****Patient preference
**Rate control with:
**Rate control with:
***[[Diltiazem]]
***[[Diltiazem]]
***[[Metoprolol]]
***[[Metoprolol]]
***MTP (good in setting of ACS)
***[[Amiodarone]] (good in setting of hypotension, CHF)
***[[Amiodarone]] (good in setting of hypotension, CHF)
***[[Digoxin]] (good in setting of CHF)
***[[Digoxin]] (good in setting of CHF)
**Synchronized [[Cardioversion]] (120-200 J)
**Rhythm conversion with:
***Synchronized [[Cardioversion]] (120-200 J)
****Best performed on patients with new onset A fib or patients fully therapeutically anti-coagulated for > 3 weeks
***Procainamide [[Ottawa Aggressive ED Cardioversion Protocol]]

Revision as of 21:08, 11 March 2019

Narrow Irregular Tachycardia

  • Multi-focal atrial tachycardia (MAT)
    • Treat underlying cause (hypokalemia, hypomagnesemia)
    • If not symptomatic and rate < 110/120 bpm, may not require treatment (e.g., patient with MAT secondary to COPD)
  • Sinus Tachycardia with frequent PACs
    • Treat underlying cause
  • A fib / A Flutter with variable conduction (see also Atrial Fibrillation with RVR)
    • Check if patient has taken usual rate-control meds
      • If missed dose, may provide dose of home medication and observe for resolution
    • Determine whether patient is better candidate for rate control or rhythm control [1]
      • Rate control preferred with:
        • Persistent A fib
        • Less symptomatic patients
        • Age 65 or older
        • Hypertension
        • No heart failure
        • Previous failure to cardiovert
        • Patient preference
      • Rhythm control preferred with:
        • Paroxismal or new A fib
        • More symptomatic patients
        • Age < 65 years
        • Heart failure clearly exacerbated by A fib
        • No history of rhythm control failure
        • Patient preference
    • Rate control with:
    • Rhythm conversion with:
  1. Frankel, G. et al. (2013) Rate versus rhythm control in atrial fibrillation. Canadian Family Physician 59(2), 161 - 168